Latest News & Insights
Stay Up to Date with Our Community
Featured
February 14, 2024
Westlake-backed Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target pain at its source, today announced...
Loading...
February 14, 2024
Westlake-backed Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain...
February 12, 2024
EMERYVILLE, Calif., Feb. 12, 2024 -- Kyverna Therapeutics, Inc. (Kyverna), a...
July 17, 2023
Westlake today announced the launch of its third fund of $450...
June 8, 2023
Westlake-backed Kate Therapeutics Inc., a next-generation gene therapy company, today emerged...
June 6, 2023
Mira Chaurushiya, Managing Director at Westlake Village BioPartners, has been named...
May 26, 2023
On May 19, Westlake Village BioPartners was named Business of the...
December 20, 2022
Kite, a Gilead Company (Nasdaq: GILD), and Westlake-backed Tmunity Therapeutics (Tmunity),...
December 8, 2022
Dantari, Inc., a clinical-stage biotechnology company developing best-in-class targeted therapeutics for...
September 27, 2022
Arsenal Biosciences, Inc., a privately held programmable cell therapy company engineering...